» Articles » PMID: 22073238

MiR-223 Suppresses Cell Proliferation by Targeting IGF-1R

Overview
Journal PLoS One
Date 2011 Nov 11
PMID 22073238
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

To study the roles of microRNA-223 (miR-223) in regulation of cell growth, we established a miR-223 over-expression model in HeLa cells infected with miR-223 by Lentivirus pLL3.7 system. We observed in this model that miR-223 significantly suppressed the proliferation, growth rate, colony formation of HeLa cells in vitro, and in vivo tumorigenicity or tumor formation in nude mice. To investigate the mechanisms involved, we scanned and examined the potential and putative target molecules of miR-223 by informatics, quantitative PCR and Western blot, and found that insulin-like growth factor-1 receptor (IGF-1R) was the functional target of miR-223 inhibition of cell proliferation. Targeting IGF-1R by miR-223 was not only seen in HeLa cells, but also in leukemia and hepatoma cells. The downstream pathway, Akt/mTOR/p70S6K, to which the signal was mediated by IGF-1R, was inhibited as well. The relative luciferase activity of the reporter containing wild-type 3'UTR(3'untranslated region) of IGF-1R was significantly suppressed, but the mutant not. Silence of IGF-1R expression by vector-based short hairpin RNA resulted in the similar inhibition with miR-223. Contrarily, rescued IGF-1R expression in the cells that over-expressed miR-223, reversed the inhibition caused by miR-223 via introducing IGF-1R cDNA that didn't contain the 3'UTR. Meanwhile, we also noted that miR-223 targeted Rasa1, but the downstream molecules mediated by Rasa1 was neither targeted nor regulated. Therefore we believed that IGF-1R was the functional target for miR-223 suppression of cell proliferation and its downstream PI3K/Akt/mTOR/p70S6K pathway suppressed by miR-223 was by targeting IGF-1R.

Citing Articles

Can circulating microRNAs predict colorectal cancer? Results from a nested case-control study of pre-diagnostic serum samples from two prospective biobanks.

Hofsli E, Saetrom P, Ness-Jensen E, Surcel H, Mjelle R BMC Cancer. 2025; 25(1):455.

PMID: 40082755 PMC: 11905635. DOI: 10.1186/s12885-025-13854-1.


miR-223 and Chromogranin A Affect Inflammatory Immune Cell Activation in Liver Metastasis of Neuroendocrine Neoplasms.

Geisler L, Detjen K, Hellberg T, Kohlhepp M, Grotzinger C, Knorr J Cells. 2025; 14(2).

PMID: 39851539 PMC: 11763622. DOI: 10.3390/cells14020111.


Circulating MicroRNAs Related to Arterial Stiffness in Adults with HIV Infection.

Nanoudis S, Yavropoulou M, Tsachouridou O, Pikilidou M, Pilalas D, Kotsa K Viruses. 2025; 16(12.

PMID: 39772253 PMC: 11680088. DOI: 10.3390/v16121945.


Single-nucleus and spatial transcriptomics of paediatric ovary: Molecular insights into the dysregulated signalling pathways underlying premature ovarian insufficiency in classic galactosemia.

Kavarthapu R, Lou H, Pham T, Do H, Soliman M, Badger T Clin Transl Med. 2024; 14(10):e70043.

PMID: 39440457 PMC: 11812122. DOI: 10.1002/ctm2.70043.


miRNAs that regulate apoptosis in breast cancer and cervical cancer.

Beilankouhi E, Maghsoodi M, Zamani Sani M, Khosroshahi N, Zarezadeh R, Nargesi M Cell Biochem Biophys. 2024; 82(3):1993-2006.

PMID: 38969951 DOI: 10.1007/s12013-024-01405-7.


References
1.
Wu L, Zhao Q, Zhu X, Peng M, Jia C, Wu W . A novel function of microRNA let-7d in regulation of galectin-3 expression in attention deficit hyperactivity disorder rat brain. Brain Pathol. 2010; 20(6):1042-54. PMC: 8094722. DOI: 10.1111/j.1750-3639.2010.00410.x. View

2.
Fazi F, Rosa A, Fatica A, Gelmetti V, De Marchis M, Nervi C . A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell. 2005; 123(5):819-31. DOI: 10.1016/j.cell.2005.09.023. View

3.
Liu L, Zheng J, Wang X, Jiang B . Endothelial p70 S6 kinase 1 in regulating tumor angiogenesis. Cancer Res. 2008; 68(19):8183-8. DOI: 10.1158/0008-5472.CAN-08-0819. View

4.
Lopiccolo J, Blumenthal G, Bernstein W, Dennis P . Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations. Drug Resist Updat. 2008; 11(1-2):32-50. PMC: 2442829. DOI: 10.1016/j.drup.2007.11.003. View

5.
Park S, Chapuis N, Tamburini J, Bardet V, Cornillet-Lefebvre P, Willems L . Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia. Haematologica. 2009; 95(5):819-28. PMC: 2864389. DOI: 10.3324/haematol.2009.013797. View